Item 1. Business OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into p…
Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Item 1. Business OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage bi…
n, future events or otherwise . Table of Contents SUMMARY OF RISK FACTORS Our business is subject to risks of which you should be aware before making an investment decision. The risks described b…
Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Reciprocal relationship from FBIO…
Mustang Bio, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MBIO-DEBT-10879
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
MBIO-DEBT-10878
Warrants outstanding: 288184
90%
xbrl warrant detail from xbrl 2026-03-31.
Mustang Bio, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Mustang Bio, Inc..
Mustang Bio, Inc. Ownership
Holder
Name
Confidence
Evidence
MBIO-OWNER-KESTRA-ADVISORY-SERVICES-LLC
Kestra Advisory Services, LLC
90%
13F overlay lists Kestra Advisory Services, LLC as top holder; 22 tracked holders.